Diagnostic Microbiology and Infectious Disease

Papers
(The TQCC of Diagnostic Microbiology and Infectious Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)81
The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review78
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection60
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals54
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays51
Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection center46
Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples45
COVID-19 in Brazil: 150,000 deaths and the Brazilian underreporting41
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection38
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type36
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities34
The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.34
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review32
Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-1932
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study31
Activity of aztreonam in combination with ceftazidime–avibactam against serine- and metallo-β-lactamase–producing Pseudomonas aeruginosa30
Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples28
Laboratory evaluation of the BioFire FilmArray Pneumonia plus panel compared to conventional methods for the identification of bacteria in lower respiratory tract specimens: a prospective cross-sectio28
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies28
Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel28
Advances in rapid diagnostics for bloodstream infections28
Changes in healthcare managing COVID and non–COVID-19 patients during the pandemic: striking the balance27
Detection of SARS-CoV-2 IgG antibodies in dried blood spots27
Time to positivity of acute and chronic periprosthetic joint infection cultures25
A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia25
In vitro activity of Ceftazidime–Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 201924
Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals24
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection24
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)24
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-223
Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?22
Prospective clinical validation of 3D printed nasopharyngeal swabs for diagnosis of COVID-1921
Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing21
Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis21
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-201821
Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave20
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test20
Targeted next generation sequencing for elbow periprosthetic joint infection diagnosis19
SARS-CoV-2 IgG antibody responses in New York City19
Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection18
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States18
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study18
A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease18
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia18
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii17
Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia17
Respiratory bacterial pathogen spectrum among COVID-19 infected and non–COVID-19 virus infected pneumonia patients17
Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens16
Balamuthia mandrillaris encephalitis in a child: case report and literature review16
Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature16
Systematic analysis, identification, and use of CRISPR/Cas13a–associated crRNAs for sensitive and specific detection of the lcrV gene of Yersinia pestis16
Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination16
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using16
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report16
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5– and IMP-7–type carbapenemases in a tertiary hospital15
Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays15
Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients14
Evaluation and comparison of automated and manual ELISA for diagnosis of chronic pulmonary aspergillosis (CPA) in Indonesia14
Performance of a rapid antigen test for SARS-CoV-2 in Kenya14
Evaluation of diagnostic accuracy of loop-mediated isothermal amplification method (LAMP) compared with polymerase chain reaction (PCR) for Leptospira spp. in clinical samples: a systematic review and14
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value14
A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-214
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022)14
A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect14
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection14
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables14
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs14
Evaluation of the Abbott PanbioTM COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians14
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-201913
Plasma cell-free metagenomic next generation sequencing in the clinical setting for the diagnosis of infectious diseases: a systematic review and meta-analysis13
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test13
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening13
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG13
Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.13
Microbiological diagnosis of Acanthamoebic keratitis: experience from tertiary care center of North India13
Comparison of reverse-transcription qPCR and droplet digital PCR for the detection of SARS-CoV-2 in clinical specimens of hospitalized patients13
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays13
Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection13
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China12
Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?12
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals12
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years12
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients12
Respiratory co-infections with COVID-19 in the Veterans Health Administration, 202012
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus12
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories12
Comparison of SARS-CoV-2 molecular detection in nasopharyngeal swab, saliva, and gargle samples12
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection12
Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays11
Negative impact of the COVID-19 pandemic on the timely diagnosis of tick-borne infections11
Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-201911
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay11
Accelerating the global response against the exponentially growing COVID-19 outbreak through decent data sharing11
The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation11
Assay dependence of long-term kinetics of SARS-CoV-2 antibodies11
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States10
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from Unit10
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma10
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-1910
Predictive ability of LRINEC score in the prediction of limb loss and mortality in diabetic foot infection10
Development and validation of a new scoring system for the early diagnosis of tuberculous meningitis in adults10
Abbott ID now COVID-19 assay performance: a year in review10
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform10
Staphylococcus pettenkoferi-positive Blood cultures in Hospitalized Patients in a Multi-site Tertiary Center10
Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients10
Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients10
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients10
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study10
Sensitivity and specificity of multibacillary and paucibacillary leprosy laboratory tests: A systematic review and meta-analysis10
Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients9
A deletion in the N gene may cause diagnostic escape in SARS-CoV-2 samples9
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales9
SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil9
False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease9
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study9
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates9
Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays9
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012–2018)9
Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis9
A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy9
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia9
A quantitative enzyme-linked immunoassay (ELISA) to approximate complement-fixing antibody titers in serum from patients with coccidioidomycosis9
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales9
In vitro activity of ceftaroline and ceftobiprole against clinical isolates of Gram-positive bacteria from infective endocarditis: are these drugs potential options for the initial management of this 9
Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department9
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD stud9
In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014–2017 and 20189
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity9
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis8
Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-28
Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant8
The diagnostic and clinical utility of microbial cell-free DNA sequencing in a real-world setting8
Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India8
Comparison of mortality, stroke, and relapse for methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infective endocarditis: a retrospective cohort study8
Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)8
Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence8
Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples8
Microbiota and parasite relationship8
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs8
Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an Emergency Department8
Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient8
Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes8
Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response8
Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population8
High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana8
COVID-19 in Brazil: a 3-year update7
Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil7
Characterization of abscesses from liver, pancreas and kidney using deep sequencing of the 16S rRNA gene7
Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 – 20207
Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 20177
Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-27
Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort7
IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination7
Performance of PhenoMatrix for the detection of Group B Streptococcus from recto-vaginal swabs7
Evaluation of five widely used serologic assays for antibodies to SARS-CoV-27
Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease7
Dissemination of NDM-producing bacteria in Southern Brazil7
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-197
Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France7
Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system7
Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection7
Evaluation of automated antigen detection test for detection of SARS-CoV-27
Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains7
Detection of potential enteric pathogens in children with severe acute gastroenteritis using the filmarray: Results from a three - years hospital-based survey in Northern Italy7
Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-27
Coinfections among hospitalized patients with covid-19 in the first pandemic wave7
The challenge of COVID-19 for a Clinical Microbiology Department7
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011–20187
Pooling samples: a testing option for SARS-CoV-2 during a supply shortage7
In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China7
Dynamics of nosocomial parainfluenza virus type 3 and influenza virus infections at a large German University Hospital between 2012 and 20196
Evaluation of the Cepheid Xpert SA Nasal Complete for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in nasal swabs from pediatric patients6
Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years6
Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies6
Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings6
Rapid and sensitive detection of SARS-CoV-2 variants in nasopharyngeal swabs and wastewaters6
Impact of RNA degradation on influenza diagnosis in the surveillance system6
Frequency of natural antibodies and concordance analysis for anti-TOXOPLASMA IgM tests in Colombian sera of pregnant women6
Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing6
Rapid detection of carbapenemase-producing Pseudomonas spp. using the NitroSpeed-Carba NP test6
Analytical and clinical evaluation of new automated chemiluminescent immunoassays for the detection of IgG and IgM anti-Bartonella henselae antibodies6
Development of a species-specific real-time PCR test for Chlamydia psittaci and its employment in the investigation of zoonotic transmission from racing pigeons in Denmark6
Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel6
Enterococcus faecalis in blood cultures—a prospective study on the role of persistent bacteremia6
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity6
Mobile genetic elements responsible for discordant Staphylococcus aureus phenotypes and genotypes in the same blood culture bottle6
Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis6
Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia6
Clinical evaluation of dithiothreitol in comparison with sonication for biofilm dislodgement in the microbiological diagnosis of periprosthetic joint infection6
SARS-CoV-2 diagnostics: Some reflections on current assays6
Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification6
Fast and reliable detection of carbapenemase genes in various Gram negatives using a new commercially available fluorescence-based real-time polymerase chain reaction platform6
Epidemiology and regional variation of nonsusceptible and multidrug-resistant Pseudomonas aeruginosa isolates from intensive versus non-intensive care units across multiple centers in the United State6
A real-time multiplex PCR assay for detection of the causative agents of rat bite fever, Streptobacillus moniliformis and zoonoticStreptobacillus species6
Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay6
Efficient automated semi-quantitative urine culture analysis via BD Urine Culture App6
Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 20026
Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog® system, a metabolic phenotyping assay6
Concern levels of beta-lactamase-producing Gram-negative bacilli in hospital wastewater: hotspot of antimicrobial resistance in Latin-America6
Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay6
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus6
Performance of ceftriaxone susceptibility testing on the Accelerate Pheno® system of ESBL-producing isolates6
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada – SMART 2018-20195
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations5
Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study5
Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam5
Evaluation of novel immunological rapid test (K.N.I.V.O. Detection K-Set) for rapid detection of carbapenemase producers in multidrug-resistant gram negatives5
COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine?5
An Australian diagnostic microbiology surge response to the COVID-19 pandemic5
Target capture sequencing of SARS-CoV-2 genomes using the ONETest Coronaviruses Plus5
Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening5
microRNA as biomarkers in tuberculosis: a new emerging molecular diagnostic solution5
Do written diagnosis-treatment recommendations on microbiological test reports improve the management of Staphylococcus aureus bacteremia? A single-center, retrospective, observational study5
Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment5
Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?5
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic backgroun5
Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China5
CagE, cagA and cagA 3′ region polymorphism of Helicobacter pylori and their association with the intra-gastric diseases in Moroccan population5
Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology5
Identification of Streptococcus dysgalactiae using matrix-assisted laser desorption/ionization-time of flight mass spectrometry; refining the database for improved identification5
Aggregation of data from 4 clinical studies demonstrating efficacy of single-dose doxycycline postexposure for prevention of the spirochetal infections: Lyme disease, syphilis, and tick-borne relapsin5
The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center5
SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: a clinical cohort study5
SARS-CoV-2 variant detection with ADSSpike5
Whole-genome analysis of SARS-CoV-2 samples indicate no tissue specific genetic adaptation of the virus in COVID-19 patients’ upper and lower respiratory tract5
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes5
Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms5
Diagnostic value of bronchoalveolar lavage fluid cryptococcal antigen-lateral flow immunochromatographic assay for pulmonary cryptococcosis in non-HIV patients4
Impact of COVID-19 pandemic on blood culture practices and bacteremia epidemiology4
Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis4
Application of digital PCR to determine the reliability of Xpert Xpress SARS-CoV-2 assay with envelope (E) gene negative and nucleocapsid (N2) gene positive results4
Comparison of the Bruker Microflex LT and Zybio EXS2600 MALDI TOF MS systems for the identification of clinical microorganisms4
Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children4
Stability of MERS-CoV RNA on spin columns of RNA extraction kit at room temperature4
Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center4
Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management4
Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observat4
Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hosp4
Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels4
Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections4
False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity4
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays4
The use of BCYE medium for the detection of Legionella in environmental water samples: an appropriate update to ISO 11731:2017 standard?4
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario4
Real-time PCR assays to detect 10 Shiga toxin subtype (Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g) genes4
Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources4
The utility of the syphilis enzyme immunoassay IgM in the diagnosis of congenital syphilis4
Microbiological investigation of samples collected from healthy middle ears during cochlear implant surgery4
Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs4
An inventory of 44 qPCR assays using hydrolysis probes operating with a unique amplification condition for the detection and quantification of antibiotic resistance genes4
0.052448987960815